| 30 Tage | 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 5% | 8.2% | 15.1% |
| Erfolgsquote | 84% | 68% | 82% |
| Transaktionen |
33
0% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Chief Financial Officer, Secretary, IR Contact Officer | BioLife Solutions, Inc. | 1. Januar 2017 - |
| Independent Director | Pareteum Corp | 23. September 2015 - 31. Dezember 2017 |
| Chief Financial Officer, Secretary | BioLife Solutions, Inc. | 3. Mai 2016 - 1. Januar 2017 |
| Interim Chief Financial Officer, Interim Secretary | BioLife Solutions, Inc. | 4. März 2016 - 3. Mai 2016 |
| Independent Director | BioLife Solutions, Inc. | 19. Juni 2000 - 19. November 2013 |
| Chairman of the Board, Interim President and Treasurer | Cambridge Heart Inc | 4. Januar 2013 - 4. November 2013 |
| Independent Director | Endologix Inc | 1. November 2003 - 23. Mai 2013 |
| Chairman of the Board | Cambridge Heart Inc | 24. November 2008 - 4. Januar 2013 |
Plus schaltet den vollständigen Transaktionsverlauf frei.
Monatliche Abrechnung · Jederzeit kündbar